Contrast ultrasound and targeted microbubbles: Diagnostic and therapeutic applications for angiogenesis

Journal of Cardiovascular Translational Research

Volumn 4, Issue 4, 2011, Pages 404-415

  Smith, Alexandra H ^a   Fujii, Hiroko ^a   Kuliszewski, Michael A ^a   Leong Poi, Howard ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Angiogenesis; Contrast ultrasound; Molecular imaging; Ultrasound mediated gene delivery

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR 4; MICROSPHERE; PLACEBO; PLASMID DNA; SCATTER FACTOR; VASCULOTROPIN 165; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ARTICLE; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG ADMINISTRATION ROUTE; ECHOCARDIOGRAPHY; GENE THERAPY; GENETIC TRANSFECTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MICROBUBBLE; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND MEDIATED GENE DELIVERY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MICROBUBBLES; MOLECULAR IMAGING; NEOVASCULARIZATION, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; TRANSLATIONAL RESEARCH; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79960469158     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-011-9282-2     Document Type: Article

References (60)

1. P Carmeliet 2000 Mechanisms of angiogenesis and arteriogenesis Nat Med 6 4 389 395 10742145 10.1038/74651 1:CAS:528:DC%2BD3cXisVOrur4%3D (Pubitemid 30208155)
2. CJ Drake 2003 Embryonic and adult vasculogenesis Birth Defects Res C Embryo Today 69 1 73 82 12768659 10.1002/bdrc.10003 1:CAS:528: DC%2BD3sXjsVKhsr4%3D (Pubitemid 37238417)
3. P Carmeliet 2003 Angiogenesis in health and disease Nat Med 9 6 653 660 12778163 10.1038/nm0603-653 1:CAS:528:DC%2BD3sXktFOntbY%3D (Pubitemid 36749213)
4. SL Mulvagh H Rakowski MA Vannan SS Abdelmoneim H Becher SM Bierig, et al. 2008 American society of echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography J Am Soc Echocardiogr 21 11 1179 1201 18992671 10.1016/j.echo.2008.09.009 quiz 1281
5. S Kaul 1997 Myocardial contrast echocardiography: 15 years of research and development Circulation 96 10 3745 3760 9396479 1:STN:280: DyaK1c%2FlslWltw%3D%3D (Pubitemid 27513457)
6. M Nahrendorf DE Sosnovik BA French FK Swirski F Bengel MM Sadeghi, et al. 2009 Multimodality cardiovascular molecular imaging, part II Circ Cardiovasc Imaging 2 1 56 70 19808565 10.1161/CIRCIMAGING.108.839092
7. AJ Sinusas F Bengel M Nahrendorf FH Epstein JC Wu FS Villanueva, et al. 2008 Multimodality cardiovascular molecular imaging, part I Circ Cardiovasc Imaging 1 3 244 256 19808549 10.1161/CIRCIMAGING.108.824359
8. JR Lindner J Song AR Jayaweera J Sklenar S Kaul 2002 Microvascular rheology of definity microbubbles after intra-arterial and intravenous administration J Am Soc Echocardiogr 15 5 396 403 12019422 10.1067/mje.2002. 117290 (Pubitemid 46002653)
9. FS Villanueva WR Wagner 2008 Ultrasound molecular imaging of cardiovascular disease Nat Clin Pract Cardiovasc Med 5 Suppl 2 S26 S32 18641604 10.1038/ncpcardio1246 1:CAS:528:DC%2BD1cXoslensbc%3D
10. H Leong-Poi 2009 Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy Cardiovasc Res 84 2 190 200 19628466 10.1093/cvr/cvp248 1:CAS:528:DC%2BD1MXht1OrtLrE
11. JR Lindner 2004 Molecular imaging with contrast ultrasound and targeted microbubbles J Nucl Cardiol 11 2 215 221 15052252 10.1016/j.nuclcard.2004.01.003 (Pubitemid 38949915)
12. H Leong-Poi J Christiansen AL Klibanov S Kaul JR Lindner 2003 Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins Circulation 107 3 455 460 12551871 10.1161/01.CIR.0000044916. 05919.8B 1:CAS:528:DC%2BD3sXks1eksQ%3D%3D (Pubitemid 36158049)
13. DA Sipkins DA Cheresh MR Kazemi LM Nevin MD Bednarski KC Li 1998 Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 5 623 626 9585240 10.1038/nm0598-623 1:CAS:528:DyaK1cXjtFKgtr4%3D (Pubitemid 28237365)
14. Z Wu ZB Li K Chen W Cai L He FT Chin, et al. 2007 microPET of tumor integrin alphavbeta3 expression using 18 F-labeled PEGylated tetrameric RGD peptide (18 F-FPRGD4) J Nucl Med 48 9 1536 1544 17704249 10.2967/jnumed.107. 040816 1:CAS:528:DC%2BD2sXhtFGgsLnI (Pubitemid 47397404)
15. RR Hantgan MC Stahle JH Connor DS Lyles DA Horita M Rocco, et al. 2004 The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization J Mol Biol 342 5 1625 1636 15364586 10.1016/j.jmb.2004.08.009 1:CAS:528:DC%2BD2cXnsFSisLk%3D (Pubitemid 39208683)
16. SM Stieger PA Dayton MA Borden CF Caskey SM Griffey ER Wisner, et al. 2008 Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents Contrast Media Mol Imaging 3 1 9 18 18335479 10.1002/cmmi.224 1:CAS:528:DC%2BD1cXktVertr4%3D (Pubitemid 351493974)
17. H Leong-Poi J Christiansen P Heppner CW Lewis AL Klibanov S Kaul, et al. 2005 Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression Circulation 111 24 3248 3254 15956135 10.1161/CIRCULATIONAHA.104.481515 1:CAS:528:DC%2BD2MXltVKmtr4%3D (Pubitemid 40874997)
18. G Korpanty JG Carbon PA Grayburn JB Fleming RA Brekken 2007 Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature Clin Cancer Res 13 1 323 330 17200371 10.1158/1078-0432.CCR-06-1313 1:CAS:528:DC%2BD2sXotlag (Pubitemid 46121886)
19. CZ Behm BA Kaufmann C Carr M Lankford JM Sanders CE Rose, et al. 2008 Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis Circulation 117 22 2902 2911 18506006 10.1161/CIRCULATIONAHA.107. 744037 1:CAS:528:DC%2BD1cXmsVOjs7Y%3D (Pubitemid 351787072)
20. I Tardy S Pochon M Theraulaz P Emmel L Passantino F Tranquart, et al. 2010 Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55 Invest Radiol 45 10 573 578 20808233 10.1097/RLI.0b013e3181ee8b83 1:CAS:528:DC%2BC3cXhtFOktLbK
21. S Pochon I Tardy P Bussat T Bettinger J Brochot M von Wronski, et al. 2010 BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis Invest Radiol 45 2 89 95 20027118 10.1097/RLI.0b013e3181c5927c 1:CAS:528:DC%2BC3cXps1SrtA%3D%3D
22. M Simons RO Bonow NA Chronos DJ Cohen FJ Giordano HK Hammond, et al. 2000 Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary Circulation 102 11 E73 E86 10982554 1:STN:280: DC%2BD3cvls1KksA%3D%3D
23. M Simons JA Ware 2003 Therapeutic angiogenesis in cardiovascular disease Nat Rev Drug Discov 2 11 863 871 14668807 10.1038/nrd1226 1:CAS:528: DC%2BD3sXpt1agtbc%3D (Pubitemid 37407792)
24. Y Taniyama K Tachibana K Hiraoka M Aoki S Yamamoto K Matsumoto, et al. 2002 Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle Gene Ther 9 6 372 380 11960313 10.1038/sj.gt.3301678 1:CAS:528:DC%2BD38XisFGgtbk%3D (Pubitemid 34414035)
25. CL Grines MW Watkins G Helmer W Penny J Brinker JD Marmur, et al. 2002 Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris Circulation 105 11 1291 1297 11901038 10.1161/hc1102.105595 1:CAS:528: DC%2BD38XjtFals7g%3D (Pubitemid 34260418)
26. J Kastrup E Jorgensen A Ruck K Tagil D Glogar W Ruzyllo, et al. 2005 Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 7 982 988 15808751 10.1016/j.jacc.2004.12.068 1:CAS:528:DC%2BD2MXivV2hu70%3D (Pubitemid 40432426)
27. DJ Stewart MJ Kutryk D Fitchett M Freeman N Camack Y Su, et al. 2009 VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial MolTher 17 6 1109 1115 1:CAS:528:DC%2BD1MXktFWju78%3D
28. M Simons 2005 Angiogenesis: where do we stand now? Circulation 111 12 1556 1566 15795364 10.1161/01.CIR.0000159345.00591.8F (Pubitemid 40470653)
29. OJ Muller HA Katus R Bekeredjian 2007 Targeting the heart with gene therapy-optimized gene delivery methods CardiovascRes 73 3 453 462 10.1016/j.cardiores.2006.09.021 (Pubitemid 46084926)
30. W Ding L Zhang Z Yan JF Engelhardt 2005 Intracellular trafficking of adeno-associated viral vectors Gene Ther 12 11 873 880 15829993 10.1038/sj.gt.3302527 1:CAS:528:DC%2BD2MXktlClu74%3D (Pubitemid 40852205)
31. LG Melo R Agrawal L Zhang M Rezvani AA Mangi A Ehsan, et al. 2002 Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene Circulation 105 5 602 607 11827926 10.1161/hc0502.103363 1:CAS:528:DC%2BD38XhslGgs7g%3D (Pubitemid 34123435)
32. L Li H Okada G Takemura K Kosai H Kanamori M Esaki, et al. 2009 Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction Am J Physiol Heart Circ Physiol 297 4 H1504 H1513 19684189 10.1152/ajpheart.00194.2009 1:CAS:528:DC%2BD1MXhtlent73O
33. SM Samuel Y Akita D Paul M Thirunavukkarasu L Zhan PR Sudhakaran, et al. 2010 Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats Diabetes 59 1 51 60 19794062 10.2337/db09-0336 1:CAS:528:DC%2BC3cXmtVKgtg%3D%3D
34. T Kawada M Nakazawa S Nakauchi K Yamazaki R Shimamoto M Urabe, et al. 2002 Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters Proc Natl Acad Sci USA 99 2 901 906 11805334 10.1073/pnas.022641799 1:CAS:528: DC%2BD38Xht1WisLk%3D (Pubitemid 34106608)
35. M Hoshijima Y Ikeda Y Iwanaga S Minamisawa MO Date Y Gu, et al. 2002 Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery Nat Med 8 8 864 871 12134142 1:CAS:528:DC%2BD38Xls12mtr0%3D
36. M Laitinen T Pakkanen E Donetti R Baetta J Luoma P Lehtolainen, et al. 1997 Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses Hum Gene Ther 8 14 1645 1650 9322866 10.1089/hum.1997.8.14-1645 1:CAS:528:DyaK2sXmsFersr4%3D (Pubitemid 28031582)
37. I Baumgartner A Pieczek O Manor R Blair M Kearney K Walsh, et al. 1998 Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 12 1114 1123 9537336 1:CAS:528:DyaK1cXisVWmsrk%3D (Pubitemid 28152883)
38. JM Isner A Pieczek R Schainfeld R Blair L Haley T Asahara, et al. 1996 Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Lancet 348 9024 370 374 8709735 10.1016/S0140- 6736(96)03361-2 1:STN:280:DyaK28zit1agsg%3D%3D (Pubitemid 26261511)
39. DW Losordo PR Vale RC Hendel CE Milliken FD Fortuin N Cummings, et al. 2002 Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia Circulation 105 17 2012 2018 11980678 10.1161/01.CIR.0000015982.70785.B7 1:CAS:528:DC%2BD38Xkt1Cht70%3D (Pubitemid 34465261)
40. DW Losordo PR Vale JF Symes CH Dunnington DD Esakof M Maysky, et al. 1998 Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 25 2800 2804 9860779 1:CAS:528:DyaK1MXjs1ChsA%3D%3D (Pubitemid 29003959)
41. TD Henry CL Grines MW Watkins N Dib G Barbeau R Moreadith, et al. 2007 Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials J Am Coll Cardiol 50 11 1038 1046 17825712 10.1016/j.jacc.2007.06.010 1:CAS:528:DC%2BD2sXhtVWhtrnL (Pubitemid 47354223)
42. R Bekeredjian PA Grayburn RV Shohet 2005 Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine J Am Coll Cardiol 45 3 329 335 15680708 10.1016/j.jacc.2004.08.067 1:CAS:528:DC%2BD2MXoslChsA%3D%3D (Pubitemid 40186780)
43. R Bekeredjian S Chen PA Frenkel PA Grayburn RV Shohet 2003 Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart Circulation 108 8 1022 1026 12912823 10.1161/01.CIR.0000084535.35435.AE (Pubitemid 37048235)
44. JP Christiansen BA French AL Klibanov S Kaul JR Lindner 2003 Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles Ultrasound Med Biol 29 12 1759 1767 14698343 10.1016/S0301-5629(03) 00976-1 (Pubitemid 38091725)
45. RJ Price DM Skyba S Kaul TC Skalak 1998 Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound Circulation 98 13 1264 1267 9751673 1:STN:280:DyaK1cvis1WjtQ%3D%3D (Pubitemid 28443388)
46. DM Skyba RJ Price AZ Linka TC Skalak S Kaul 1998 Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue Circulation 98 4 290 293 9711932 1:STN:280: DyaK1cznsFOmsg%3D%3D (Pubitemid 28348049)
47. J Song JC Chappell M Qi EJ VanGieson S Kaul RJ Price 2002 Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle J Am Coll Cardiol 39 4 726 731 11849875 10.1016/S0735-1097(01)01793-4 (Pubitemid 34158172)
48. S Chen RV Shohet R Bekeredjian P Frenkel PA Grayburn 2003 Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction J Am Coll Cardiol 42 2 301 308 12875768 10.1016/S0735-1097(03)00627-2 1:CAS:528: DC%2BD3sXotFahtrY%3D (Pubitemid 36851422)
49. G Korpanty S Chen RV Shohet J Ding B Yang PA Frenkel, et al. 2005 Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles Gene Ther 12 17 1305 1312 15829992 10.1038/sj.gt.3302532 1:CAS:528:DC%2BD2MXos1eksbY%3D (Pubitemid 43084486)
50. J Suzuki M Ogawa K Takayama Y Taniyama R Morishita Y Hirata, et al. 2010 Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice J Am Coll Cardiol 55 9 904 913 20185042 10.1016/j.jacc.2009.09.054 1:CAS:528:DC%2BC3cXktF2qs7Y%3D
51. H Inagaki J Suzuki M Ogawa Y Taniyama R Morishita M Isobe 2006 Ultrasound-microbubble-mediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice J Vasc Res 43 1 12 18 16244495 10.1159/000089103 1:CAS:528:DC%2BD2MXhtlCks7bK (Pubitemid 41832706)
52. M Vannan T McCreery P Li Z Han E Unger B Kuersten, et al. 2002 Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA J Am Soc Echocardiogr 15 3 214 218 11875383 10.1067/mje.2002.119913 (Pubitemid 44964512)
53. NG Fisher JP Christiansen A Klibanov RP Taylor S Kaul JR Lindner 2002 Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement J Am Coll Cardiol 40 4 811 819 12204515 10.1016/S0735-1097(02)02038-7 1:CAS:528:DC%2BD38XntVKjsrY%3D (Pubitemid 34925631)
54. H Epstein-Barash D Gutman E Markovsky G Mishan-Eisenberg N Koroukhov J Szebeni, et al. 2010 Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death J Control Release 146 2 182 195 20359513 10.1016/j.jconrel.2010.03.011 1:CAS:528:DC%2BC3cXpvVSnsb8%3D
55. J Szebeni 1998 The interaction of liposomes with the complement system Crit Rev Ther Drug Carrier Syst 15 1 57 88 9523086 1:CAS:528:DyaK1cXitVGqtLk%3D (Pubitemid 28110564)
56. I Kondo K Ohmori A Oshita H Takeuchi S Fuke K Shinomiya, et al. 2004 Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction J Am Coll Cardiol 44 3 644 653 15358035 10.1016/j.jacc.2004.04.042 1:CAS:528: DC%2BD2cXmsVGju74%3D (Pubitemid 39078194)
57. H Leong-Poi MA Kuliszewski M Lekas M Sibbald K Teichert-Kuliszewska AL Klibanov, et al. 2007 Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle Circ Res 101 3 295 303 17585071 10.1161/CIRCRESAHA.107.148676 1:CAS:528:DC%2BD2sXotlahsbY%3D (Pubitemid 47344079)
58. J Kobulnik MA Kuliszewski DJ Stewart JR Lindner H Leong-Poi 2009 Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection J Am Coll Cardiol 54 18 1735 1742 19850216 10.1016/j.jacc.2009.07.023 1:CAS:528:DC%2BD1MXhsFait7rJ
59. H Fujii Z Sun SH Li J Wu S Fazel RD Weisel, et al. 2009 Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice JACC Cardiovasc Imaging 2 7 869 879 19608138 10.1016/j.jcmg.2009.04.008
60. H Fujii SH Li J Wu Y Miyagi TM Yau H Rakowski, et al. 2010 Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair Eur Heart J 10.1093/eurheartj/ehq475